Close

Archive for category: Research Publications

Effects of a systemic enzyme therapy in healthy active adults after exhaustive eccentric exercise: a randomized, two-stage, double-blinded, placebo-controlled trial.

Marzin T, Lorkowski G, Reule C, et al. 2017.

 

Wobenzym® plus supplementation before and after exercise increased maximum concentric strength in medium performance athletes and improved inflammatory, metabolic and immune biomarkers in all subjects.

Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.

Allaire J, Harris W, Vors C, et al. PLEFA. 2017.

 

The increase in omega-3 index was greater with supplemental DHA than EPA. The omega-3 index has been inversely associated with the risk of coronary heart disease and coronary mortality.

 

Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled Trial

Peters BA, Hall MN, Liu X, et al. J Nutr. 2016.

 

Creatine + folic acid supplementation decreased plasma guanidinoacetate and total homocystiene levels.

Folic Acid and Creatine as Therapeutic Approaches to Lower Blood Arsenic: A Randomized Controlled Trial

Peters BA, Hall MN, Liu X, et al. Envir Health Perspect. 2016.

 

PUFA showed no benefit over placebo in NASH patients with diabetes in terms of liver enzymes, body weight or body composition, and did not show a positive impact on insulin response.

Double blind randomized placebo controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis

Dasarathy S, Dasarathy J, Khiyami A, et al. J Clin Gastroenterol. 2015.

 

PUFA showed no benefit over placebo in NASH patients with diabetes in terms of liver enzymes, body weight or body composition, and did not show a positive impact on insulin response.